Dexcom Raises 2026 Outlook as Q3 Revenue Grows 11% to $1.344 Billion
DexCom, Inc. reported revenue of US$1.344 billion for the third quarter ended September 30, 2026, an 11% increase from $1.209 billion a year earlier, and paired the results with a raised full-year 2026 outlook and a new share repurchase authorization…
Abbott Amplatzer Paraclose PVL Occluder Wins FDA Approval
Abbott announced on October 28, 2026, that it has received U.S. Food and Drug Administration approval for the Amplatzer Paraclose PVL Occluder, a transcatheter device designed to treat paravalvular leak (PVL), a backflow of blood around a surgical heart valve.…
Dexcom Brings 15-Day G7 Glucose Sensor to Canadian Adults in November
DexCom, Inc. said on October 28, 2026 that its Dexcom G7 15 Day Continuous Glucose Monitoring System will be available in Canada beginning in November 2026 for adults 18 years and older living with diabetes, according to the company’s announcement…
Labcorp Raises 2026 Guidance as Q3 Adjusted EPS Climbs 14.5%
Labcorp Holdings reported revenue of $3.81 billion for the third quarter ended September 30, 2026, up 6.9% from $3.56 billion a year earlier, and raised its full-year 2026 enterprise revenue and adjusted earnings-per-share guidance, according to the company’s third-quarter earnings…
Bracco Commits $230 Million to Its First US Contrast Media Plant
Bracco announced plans on October 27, 2026, to invest $230 million to establish its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina. The Milan-based diagnostic imaging company expects the project to create 200 jobs. The company…
Stryker Closes ZuriMED Acquisition Adding Rotator Cuff Technology
Stryker has completed its acquisition of ZuriMED Technologies AG, the privately held developer of the FiberLocker System, the company announced on October 26, 2026, adding a commercialized rotator cuff augmentation technology to its Sports Medicine portfolio. The Portage, Michigan, medical…
Abbott Plans Tax-Free Spinoff of $8.5 Billion Nutrition Business
Abbott announced on October 21, 2026, that it intends to separate its global Nutrition business into an independent, publicly traded company through a distribution of shares to Abbott shareholders. According to Abbott’s announcement, the Nutrition business generates approximately $8.5 billion…
Danaher Raises 2026 EPS Outlook as Q3 Revenue Grows 8.5%
Danaher Corporation reported third-quarter 2026 results on October 21, 2026, with revenue rising 8.5% year-over-year to US$6.6 billion and net earnings of $1.2 billion, or $1.71 per diluted common share, up 34.5%. Non-GAAP adjusted diluted net earnings per common share…
Abbott Wins CE Mark for Cologuard Plus Colorectal Cancer Test
Abbott announced on October 20, 2026, from Abbott Park, Illinois, that the Cologuard Plus test has received CE Mark under the European Union’s In Vitro Diagnostic Medical Devices Regulation (IVDR), and that it plans to introduce the noninvasive, stool-based DNA…
Medtronic Swaps Remaining MiniMed Stake to Finish Separation
Medtronic plc announced on October 15, 2026 that it has completed the separation of MiniMed Group, Inc. , after exchanging its entire remaining stake in the company through an oversubscribed split-off exchange offer. Medtronic said it elected to exchange all…
GE HealthCare Wins CE Mark for MINItrace Magni Cyclotron
GE HealthCare announced on October 15, 2026, that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 production, according to a company news release. The company…
Stryker Invests $400 Million in CMR Surgical With Acquisition Option
Stryker will make an approximately $400 million (£300 million) preferred equity investment in CMR Surgical under a strategic alliance announced on October 12, 2026, gaining an exclusive option to acquire 100% of the surgical robotics company’s outstanding equity and agreeing…
Medtronic Sets MiniMed Split-Off Exchange Ratio at 4.5939 Upper Limit
Medtronic plc on October 7, 2026 announced the final exchange ratio of 4.5939 shares of MiniMed Group, Inc. common stock for each Medtronic ordinary share validly tendered and accepted in its split-off exchange offer, fixing the ratio at the offer’s…
Abbott CardioMEMS Wins FDA Approval for Patient-Facing App Features
Abbott announced on Oct. 5, 2026 that the U.S. Food and Drug Administration has approved updates to the CardioMEMS HF System that enable new patient-facing capabilities through the company’s CardioGuide HF App. For the first time, care teams can allow…
GE HealthCare Agrees to Buy SOFIE Biosciences for $945 Million
GE HealthCare has agreed to acquire SOFIE Biosciences, a U.S. contract manufacturer of positron emission tomography (PET) radiopharmaceuticals, from Trilantic North America for $945 million in cash, GE HealthCare announced on October 5, 2026. GE HealthCare said it expects the…
